Head-to-head · WeighScore
JM Integrated Health vs Zealthy
The verdict
JM Integrated Health takes it — 55.9/100 to 46.7/100.
JM Integrated Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. JM Integrated Health is a Texas-founded, Family-Nurse-Practitioner-led telehealth practice combining primary care, virtual urgent care, and medically supervised weight management across six states (TX, VT,…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | JM Integrated Health | Zealthy |
|---|---|---|
| WeighScore | 55.9/100 | 46.7/100 |
| Grade | C | C |
| Scorecard rank | #428 | #496 |
| Semaglutide | Not disclosed | $286/mo (starting dose, plus a separate fee, compounded) |
| Tirzepatide | Not disclosed | $351/mo (starting dose, plus a separate fee, compounded) |
| Coverage | 6 states | 34 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #428 · C
Strengths
- Transparent cash-pay pricing — $149 enrollment plus $99/month, no hidden fees
- Medication cost is billed separately by the pharmacy, so the program fee isn't inflated by drug markup
- Six states clearly listed (TX, VT, NM, AZ, WA, NV)
- Named provider — John Meyer, FNP-C, board-certified, 10+ years' experience
- Publishes the FDA compounded-medication disclaimer
Where it loses points
- 503A pharmacy partner not named publicly
- Single-provider practice — enrollment is capacity-limited
- Only six states served, vs nationwide competitors
- Total monthly cost is the program fee plus a separate pharmacy bill, not one all-in price
- No LegitScript certification displayed
Graded #496 · C
Strengths
- Serves 34 states — meaningful nationwide footprint
- Asynchronous model removes friction for patients who don't want a video visit
- Independent licensed prescribers retain full clinical authority
Where it loses points
- Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
- Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
- Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
- Recently rebranded to Gronk Inc. amid active enforcement
- FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.